Showing results (571-580 of 2,445) with videos related to
Sort By:
Pageof 245
Journal of the National Comprehensive Cancer Network : JNCCN|September 1, 2026
New Paradigms in the Management of Castleman DiseaseYoshito Nishimura, Thomas M Habermann, Ariela NoyJournal of the National Comprehensive Cancer Network : JNCCN|October 14, 2022
Patient, Caregiver, and Oncologist Experiences With and Perceptions of Racial Bias and Discrimination in Cancer Care DeliveryAlyssa A Schatz, Keysha Brooks-Coley, Elizabeth Harrington, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 14, 2022
Optimal Neoadjuvant Strategies for Locally Advanced Rectal Cancer by Risk Assessment and Tumor LocationAnurag Saraf, Hannah J Roberts, Jennifer Y Wo, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 14, 2022
Does Clinical Evidence of Heterogeneity Impact Treatment Selection? A Case Study of Abiraterone for Metastatic Prostate CancerBoshen Jiao, Yaw A Nyame, Josh J Carlson, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 15, 2014
Creating an adolescent and young adult cancer program: lessons learned from pediatric and adult oncology practice basesDamon Reed, Rebecca G Block, Rebecca JohnsonJournal of the National Comprehensive Cancer Network : JNCCN|June 11, 2016
Longitudinal Analysis of Severe Anxiety Symptoms in the Last Year of Life Among Patients With Advanced Cancer: Relationships With Proximity to Death, Burden, and Social SupportSiew Tzuh Tang, Jen-Shi Chen, Wen-Chi Chou, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 19, 2015
Colorectal Cancer Screening, Version 1.2015Dawn Provenzale, Kory Jasperson, Dennis J Ahnen, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 19, 2015
On the Verge: Immunotherapy for Colorectal CarcinomaDavid Y Oh, Alan P Venook, Lawrence FongJournal of the National Comprehensive Cancer Network : JNCCN|August 19, 2015
Importance of Risk Factors for Febrile Neutropenia Among Patients Receiving Chemotherapy Regimens Not Classified as High-Risk in Guidelines for Myeloid Growth Factor UseDerek Weycker, Xiaoyan Li, Rich Barron, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2016
Outcome Assessments and Cost Avoidance of an Oral Chemotherapy Management ClinicSiu-Fun Wong, Mark Bounthavong, Cham P Nguyen, et al.Pageof 245